Clinical Trial Update: The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study comparing dose-dense AC-T (doxorubicin/cyclophosphamide followed by paclitaxel) with PC (paclitaxel plus ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN